MS Tech Ltd., a leader in the development and manufacturing of nano- and biosensors, has recently been awarded a $1.2 million R&D grant by the Israel Innovation Authority. This grant is aimed at supporting the company’s Bio-Medical Division in its pioneering work on biosensor technology for the early detection of disease biomarkers in liquid biopsies. The recognition by the Israel Innovation Authority underscores the potential of MS Tech’s biosensors to revolutionize early diagnostics by providing fast, accurate, and cost-effective point-of-care solutions.

The innovative biosensors developed by MS Tech are designed to deliver results within minutes, a significant improvement over current liquid biopsy analyses that require laboratory-based, time-consuming, and costly processes. Integrated with IoT capabilities, these biosensors enable immediate data-driven decisions, eliminating operational delays and enhancing patient care. This advancement is part of the LIQUIDBX Consortium’s efforts to develop a technological infrastructure for the early detection of diseases through the analysis of multiple biological elements.

Doron Shalom, CEO of MS Tech, highlighted the company’s commitment to advancing biosensor technologies through the integration of biology, life sciences, engineering, and software. This bio-convergence approach has broad applications across medical diagnostics, agriculture, food security, and environmental protection, among other sectors. Shalom expressed gratitude for the Israel Innovation Authority’s continued support, which acknowledges MS Tech’s role at the forefront of scientific and technological innovation since its establishment in 1998.

The grant not only validates MS Tech’s leadership in biosensor innovation but also opens new avenues for collaboration and development in the field of early disease detection. With its patented sensor technologies, MS Tech is set to make a lasting impact on the healthcare industry by enabling timely interventions and improving patient outcomes through advanced diagnostics.

This news story relied on content distributed by None. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is MS Tech Secures $1.2M R&D Grant for Early Disease Detection Biosensor Technology.